BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35082531)

  • 21. Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy.
    Faraj SF; Bezerra SM; Yousefi K; Fedor H; Glavaris S; Han M; Partin AW; Humphreys E; Tosoian J; Johnson MH; Davicioni E; Trock BJ; Schaeffer EM; Ross AE; Netto GJ
    PLoS One; 2016; 11(1):e0146189. PubMed ID: 26731672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
    Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
    Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens.
    Kim H; Jung G; Kim JH; Byun SS; Hong SK
    Sci Rep; 2021 Aug; 11(1):17447. PubMed ID: 34465825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
    Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
    Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraductal carcinoma of the prostate (IDC-P) lowers apparent diffusion coefficient (ADC) values among intermediate risk prostate cancers.
    Currin S; Flood TA; Krishna S; Ansari A; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Jul; 50(1):279-287. PubMed ID: 30585372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The heterogeneous Gleason 7 carcinoma of the prostate: analyses of low and high grade (risk) carcinomas with criteria of the International Society of Urological Pathology (ISUP).
    Helpap B; Ringli D; Adler D; Wernert N; Kristiansen G
    Pathol Res Pract; 2013 Mar; 209(3):190-194. PubMed ID: 23419692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Impact of International Association of Urological Pathology Gleason scoring system on prostatic carcinoma grading: a preliminary analysis of 185 cases].
    Wang G; Shen D
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):677-9. PubMed ID: 25567594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012.
    Danneman D; Drevin L; Delahunt B; Samaratunga H; Robinson D; Bratt O; Loeb S; Stattin P; Egevad L
    BJU Int; 2017 Jan; 119(1):50-56. PubMed ID: 26918298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Basic features of the ISUP prostate carcinoma Gleason grading system: a preliminary analysis].
    Wang GW; Shen DH
    Zhonghua Nan Ke Xue; 2014 Jun; 20(6):514-7. PubMed ID: 25029856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens.
    Helpap B; Egevad L
    Virchows Arch; 2006 Dec; 449(6):622-7. PubMed ID: 17091254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8.
    Harding-Jackson N; Kryvenko ON; Whittington EE; Eastwood DC; Tjionas GA; Jorda M; Iczkowski KA
    J Urol; 2016 Oct; 196(4):1076-81. PubMed ID: 27265220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update of the Gleason grading system.
    Epstein JI
    J Urol; 2010 Feb; 183(2):433-40. PubMed ID: 20006878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.
    Kweldam CF; Kümmerlin IP; Nieboer D; Verhoef EI; Steyerberg EW; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ; van Leenders GJ
    Eur J Cancer; 2016 Oct; 66():26-33. PubMed ID: 27522247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the 2005 International Society of Urological Pathology (ISUP) consensus on Gleason grading in contemporary practice.
    Zareba P; Zhang J; Yilmaz A; Trpkov K
    Histopathology; 2009 Oct; 55(4):384-91. PubMed ID: 19817888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
    Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
    BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical small acinar proliferation and two or more cores of high-grade intraepithelial neoplasia on a previous prostate biopsy are significant predictors of cancer during a transperineal template-guided saturation biopsy aimed at sampling one core for each 1 mL of prostate volume.
    Nakai Y; Tanaka N; Miyake M; Hori S; Tatsumi Y; Morizawa Y; Fujii T; Konishi N; Fujimoto K
    Res Rep Urol; 2017; 9():187-193. PubMed ID: 29034221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists.
    Berney DM; Algaba F; Camparo P; Compérat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Montironi R; Varma M; Egevad L
    Histopathology; 2014 Feb; 64(3):405-11. PubMed ID: 24102975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.
    Dong F; Wang C; Farris AB; Wu S; Lee H; Olumi AF; McDougal WS; Young RH; Wu CL
    Am J Surg Pathol; 2012 Jun; 36(6):838-43. PubMed ID: 22592143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.
    Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
    Hum Pathol; 2014 Aug; 45(8):1572-81. PubMed ID: 24842280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.